News
-
An international team of scientists has discovered one of the causes of primary hypertension or high blood pressure. In addition, the team, led by researchers from Maastricht University (UM), discovered that this cause could be treated with existing and already registered drugs.
-
During his farewell as dean of the Faculty of Health, Medicine and Life Sciences (FHML) of Maastricht University (UM) and as vice president of the Board of Directors of Maastricht UMC+ on Friday, Prof Albert Scherpbier was awarded the highest distinction at UM, the Dr J.G.H. Tans Medal. He was also...
-
What makes one person choose a recommended healthy option and another the second-best option? According to researcher Kim Romijnders, health decisions are often based on the same common factors.
-
Pioneering research could prevent lymphoedema (PhD Maarten Beek).
-
Certain types of chemotherapy cause a greater degree of nerve damage than was previously thought (PhD conferral Tonneke Beijers).
-
The selective withdrawal of red blood cells as a treatment for haemochromatosis (iron overload) is an effective and patient-friendly alternative to phlebotomy (bloodletting) (PhD conferral Eva Rombout).
-
A new detection technique – injecting tracers into ovarian ligaments – helps to carry out a sentinel lymph node procedure in ovarian cancer. This leads to greater accuracy in detecting lymph node metastases and also leads to fewer side effects for patients.
-
On 1 November, Maastricht University has appointed Dr Fiona Godlee, editor in chief of The BMJ (formerly the British Medical Journal), as honorary professor on behalf of national research school CaRe (Netherlands School for Primary Care Research).